Skip to Main Content

Paper Details

Recurrent Tumor Cell-Intrinsic and -Extrinsic Alterations during MAPKi-Induced Melanoma Regression and Early Adaptation.
Cancer Discov
110
2017
BRAF, BRAFV600-mutant, BRAFV600-mutant melanoma, BRAFi, CD11c+ immunocytes, CD45, CD45-negative or CD45-positive fractions, IFN, MAPK, MAPKi, MAPKi-selected cell lines, MEK, Melanoma, PD, PD-L2, RTKs, T cell, T-cell inflammation, Tumor, Tumor Cell, Tumor cell, advanced, human, human melanoma cell lines, melanoma, methylome, mice, mouse, murine, murine melanoma, patient, transcriptomes, tumor, tumor cell, tumors
Author NameAffiliation
Philip O ScumpiaUniversity of California los angeles
Antoni RibasDavid Geffen School of Medicine, University of California los angeles
Antoni RibasUniversity of California los angeles
Antoni RibasJonsson Comprehensive Cancer Center, University of California los angeles
Antoni RibasUniversity of California los angeles
Antoni RibasUniversity of California los angeles
Antoni RibasDavid Geffen School of Medicine, University of California los angeles
Antoni RibasUniversity of California los angeles
Antoni RibasJonsson Comprehensive Cancer Center, University of California los angeles
Antoni RibasUniversity of California los angeles
Antoni RibasUniversity of California los angeles
  • 1 - 11

Datasets

Release 1.2